Analyst Ranking
Bottom 1%
#5205 out of 5242 analysts
Average Return
-9.88%
Win Rate
33%72 out of 219
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-20 -
2024-03-19
Buy
Anika Therapeutics IncANIK
+80.74%$8.26$14.92
2025-07-31 -
2026-04-07
Buy
Opko Health IncOPK
+65.31%$0.99$1.63
2024-02-28 -
2025-02-27
Buy
Anika Therapeutics IncANIK
+63.60%$9.12$14.92
2025-09-23 -
2026-04-07
Buy
Anika Therapeutics IncANIK
+56.72%$9.52$14.92
2026-01-09 -
2026-04-07
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Lifecore Biomedical IncLFCR
12Buy$5.50+33.82%Maintains
12 days ago
Bioventus IncBVS
2Buy$14.00+58.37%Maintains
a month ago
Opko Health IncOPK
12Buy$1.50+28.21%Maintains
a month ago
Dentsply Sirona IncXRAY
23Buy$17.00+47.57%Maintains
a month ago
Anika Therapeutics IncANIK
17Buy$17.00+13.94%Maintains
a month ago
Lemaitre Vascular IncLMAT
13Buy$105.00-4.83%Maintains
a month ago
Orthofix Medical IncOFIX
6Buy$17.00+45.18%Maintains
a month ago
Merit Medical Systems IncMMSI
26Buy$109.00+61.72%Maintains
a month ago
Henry Schein IncHSIC
19Buy$97.00+31.35%Maintains
a month ago
U S Physical Therapy IncUSPH
22Buy$103.00+37.59%Maintains
2 months ago
Haemonetics CorpHAE
25Buy$94.00+57.82%Maintains
2 months ago
Option Care Health IncOPCH
19Buy$42.00+51.41%Maintains
3 months ago
Verifyme IncVRME
11Buy$1.50+80.51%Maintains
3 months ago
Modivcare IncMODVQ
13Buy$6.00N/AMaintains
a year ago
Surmodics IncSRDX
5Buy$71.00N/AMaintains
2 years ago
Ati Physical Therapy IncATIP
1Buy$14.00N/AInitiates Coverage On
5 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.